Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma
about
Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic CancerComprehensive molecular characterization of clear cell renal cell carcinoma.Identification of ovarian cancer metastatic miRNAsCarboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot StudyMultiscale integration of -omic, imaging, and clinical data in biomedical informatics.A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.Integrated analysis of microRNA-target interactions with clinical outcomes for cancersThe inhibitory role of Mir-29 in growth of breast cancer cellsOvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancersMultiple-to-multiple relationships between microRNAs and target genes in gastric cancerHuman monocytes in the presence of interferons alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatinMicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.Clinically relevant microRNAs in ovarian cancerExpression Profile and Function Analysis of LncRNAs during Priming Phase of Rat Liver Regeneration.Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.MicroRNAs and Recent Insights into Pediatric Ovarian Cancers.Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions.miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes.Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.Circular RNAs and their associations with breast cancer subtypes.AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.Tumor-associated circulating microRNAs as biomarkers of cancer.Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Sho-saiko-to, a traditional herbal medicine, regulates gene expression and biological function by way of microRNAs in primary mouse hepatocytesRNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.The role of miRNAs in endometrial cancer.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.microRNA and Ovarian Cancer.Analysis of microRNA-target interactions across diverse cancer types.Current status on microRNAs as biomarkers for ovarian cancer.miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
P2860
Q21129296-D3EBD6E6-2A18-4367-8103-2CB3D53D9083Q27852374-0EA6DA1A-3AA3-4755-8668-DB361839B32EQ28487932-DC39B339-764A-4271-80F2-AF2ED28F7C4BQ28550381-7DA34E92-58D9-4953-921E-1CD6B6419CFEQ30581136-34ED3F8F-692B-4892-A930-2448AC2B647BQ30993887-E2A3DADF-5A13-4D8F-B50E-C10C8DA09A86Q33617181-25F64CEF-2534-4877-88FC-462BFA98E50BQ33741864-790818BB-1313-4BFD-A929-8A4ED119D867Q33912418-F41801F3-2580-4A5B-8294-A378245AD2E7Q34249355-5EEF70AC-0358-42B0-B8E8-5792AB0FC326Q34447404-52B1F32F-8877-444E-AB80-FF77E28CAF41Q34623368-B760A721-3584-44E9-BEDF-D7F715C263EAQ34717401-EE3F69EF-8C19-4B78-9684-46DBA5441EAEQ34920079-9B13998B-E346-4C2E-9562-5F1F8BEA0F4FQ35002321-04A45575-E1E1-4D38-A48A-24F0ADEE7ED7Q35140092-4EF7224F-6C1C-4B3D-A9D4-7963F94739F1Q35204609-23310155-E83C-48D4-BBA1-52B664CCA55FQ36057585-B01A5CCA-3343-4238-97EF-1AD12C7440B1Q36320168-665943AA-22F3-4284-BA98-AE1D38C8E39FQ36804155-37BAE21F-B128-4D0F-A32E-7C91E49DE041Q37088105-E45C1C1F-CD4E-4356-A05D-B21979AD2120Q37295543-642DE1A4-C19B-4072-BC93-F4072F237452Q37466755-0FDD4A51-64DF-4D70-BF47-D70CFD58C079Q37548314-9DFC7894-E067-4741-9F62-664ED10E8778Q37594361-54A8006C-F59C-413B-9187-98F0CD23EBECQ37609985-2D1A67E6-36E5-4B22-AB85-973F7D204C5CQ37697101-F6B2125A-F8DF-43E5-9146-B528796AE524Q37730639-333B699E-D32D-4B6E-B7EB-9AF28ED4AAEAQ38187323-FDCC4AB3-8D8E-4C47-86E0-07832578531FQ38256465-A15A8FEF-610E-47F9-9276-6EB1C2F584C5Q38258014-6D59BB78-633B-4237-869F-0BA793FB2853Q38309840-C4EB17E9-3F8B-4234-AF10-CF53DE660A5CQ38432883-1A07A053-525C-4111-85E8-ECC4F3FE1826Q38600963-51317DDA-88FE-48E2-8E00-4B0DA2F4D015Q38633144-F7F3B230-8842-47A0-B3CA-858678C385A4Q38667018-1C97F6DE-3C87-45EF-8CEC-DAC2EBBA344BQ38690739-A6D09D46-B662-43DE-B2CF-9ACD7DEC370DQ38711390-A4976ED1-CFC7-4AD9-B9DF-C78DAD4B8D4DQ38804354-E446BFEE-1DB2-4BE8-90F9-1242EDDCDFE1Q38819843-C050D5A2-4374-4840-BEF3-4CE78CBA3C99
P2860
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@ast
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@en
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@nl
type
label
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@ast
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@en
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@nl
prefLabel
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@ast
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@en
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@nl
P2093
P2860
P50
P3181
P1433
P1476
Integrated analyses of microRN ...... grade serous ovarian carcinoma
@en
P2093
Anadulce Hernandez-Herrera
Chad J Creighton
David A Wheeler
Douglas A Levine
Erik Larsson
Parminder Mankoo
Paul T Spellman
Preethi H Gunaratne
Richard A Gibbs
Robert Sheridan
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0034546
P407
P577
2012-01-01T00:00:00Z